COMP <GO>
PED vs XOM // FORWARD P/E MULTIPLE
Pedevco Corp. (NYSE) VS. Exxon Mobil Corporation (NYSE) • 15-METRIC TALLY: PED 2
— XOM 7
■ METRIC PARITY
LAST: $15.21 (-0.52%) • MKT CAP: $203.2M
forward-pe
—
LAST: $177.46 (-1.23%) • MKT CAP: $738.79B
forward-pe
15.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PED VS. XOM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PED | XOM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.00% | 9.86% | -12.86 | XOM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.93% | 2.59% | +2.34 | PED | /fcf-yield <GO> |
| Operating Margin | -17.20% | 10.96% | -28.16 | XOM | /operating-margins <GO> |
| Net Profit Margin | -22.60% | 7.57% | -30.17 | XOM | /net-margins <GO> |
| Revenue Growth (YoY) | 15.70% | -4.40% | +20.10 | PED | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.32% | -2.32 | XOM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.29 | 4.59 | -4.30 | XOM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.34% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 63.1 | -8.50 | XOM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.28 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 15.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $203.2M | $738.79B | -$738.58B | XOM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PED REV | XOM REV | PED GROSS % | XOM GROSS % | PED FCF | XOM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $45.8M | $332.24B | — | — | $10.8M | $23.61B |
| FY 2024 | $39.6M | $349.58B | — | — | $12.8M | $30.72B |
| FY 2023 | $30.8M | $344.58B | — | — | $23.5M | $33.45B |
| FY 2022 | — | $413.68B | — | — | — | $58.39B |
| FY 2021 | — | $285.64B | — | — | — | $36.05B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PED // BETA —
XOM // BETA 0.28